1Amett F C, Edworthy S M, Bloch D Aet al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid[J]. Arthritis Rheum, 1988;31(3) :315-324.
2Altman R, Asch E, Bleeh D etal. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteeathritis of the knee[J]. Arthritis Rheum, 1986;29(8) : 1039-1049.
3Chabaud M,Durand J M,Buchs N et al.Human interleukin-17A, T cell- derived proinflammatory cytokine produced by rheumatoid synovium [ J ]. Arthritis Rheum, 1999;42(5) :963-970.
7Ryu S,Lee J H, Kim S I. IL-17 increased the Production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes [ J ]. Clin Rheumatol, 2006; 25 ( 1 ) : 16-20.
8Honorati M C, Neri S, Cattini Let al. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts [ J ], Osteoarthritis Cartilage, 2006; 14(4) :345-352.
9Lubberts E, Koenders M I, van den Berg W B. The role of T cell interleukin-17 in conducting destructive arthritis; lessons from animal models [ J]. Arthritis Res Ther, 2005 ; 7 ( 1 ) : 29-37.
10Clavel G, Bessis N, Lemeriter D et al. Angiogenesis markers(VEGF, soluble receptor of VEGF and angiopoictin-1 )in very early arthritis and their association with inflammation and joint destruction [ J ]. Clin Immunol, 2007; 124(2) : 158-164.
3[1]Clavel G,Bessis N,Lemeiter D,et al.Angiogenesis markers(VEGF,soluble receptor of VEGF and angiopoietin-1)in very early arthritis and their association with inflammation and joint destruction[J].Clinical Immunology,2007,124(2):158-164.
4[3]Giatromanolaki A,Sivridis E,Maltesos E,et al,Upregulated hypoxia inducible factor-1 alpha and 2-alpha pathway in rheumatoid arthritis and oeleoarthritis[J].Arthritis Res Ther,2003,5(4):193-201.
5[5]Christian S,Haas M.Asif Amin,et al.Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis[J].Arhtritis and Rheumatism,2006,54(8):2402-2414.
6[6]Christian S.Haas M,AsffAmin,et al.In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis[J].Arhtritis and Rheumatism,2007,56(8):2535-2548.
7[8]De BM,BenMM,Ollivier V.et al.Blockade of vascular endotheli al growth factor receptor I(VEGFR-I),but not VEGFR Ⅱ,suppresses joint destruction in the K/BxN model of rheumatoid arthritis[J].Immunol,2003.1712(9):4853-4859.
8[9]Yoo SA,Bae DG Ryoo Jw.et al.Aginine-Rich Anti-Vascular Endothelial Growth Factor(Anti-VEGF)Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-αand IL-6 by HumaIl Monocytes[J].The Journal of Immunology,2005,174:5846-5855.
